Showing results 1 to 1 of 1
Title | Author(s) | Issue Date | |
---|---|---|---|
Cost-effectiveness of pembrolizumab compared to ipilimumab and chemotherapy as a first line treatment for patients with advanced melanoma in Hong Kong Proceeding/Conference:Annals of Oncology | 2016 |